Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.72 USD | -3.58% | +0.95% | -12.94% |
04:49am | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
05-02 | Genmab Reports Higher Interim Q1 Results; Maintains 2024 Guidance | MT |
Sales 2024 * | 19.7B 2.84B 3.87B | Sales 2025 * | 23.64B 3.4B 4.65B | Capitalization | 126B 18.11B 24.73B |
---|---|---|---|---|---|
Net income 2024 * | 5.14B 739M 1.01B | Net income 2025 * | 6.7B 965M 1.32B | EV / Sales 2024 * | 5.01 x |
Net cash position 2024 * | 27.06B 3.89B 5.32B | Net cash position 2025 * | 34.19B 4.92B 6.72B | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
24.7
x | P/E ratio 2025 * |
19.1
x | Employees | 2,204 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.87% |
Latest transcript on Genmab A/S
1 day | -3.58% | ||
1 week | +0.95% | ||
Current month | +0.11% | ||
1 month | -7.48% | ||
3 months | -0.29% | ||
6 months | -0.79% | ||
Current year | -12.94% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 98-12-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 46 | 06-12-31 |
Anthony Mancini
COO | Chief Operating Officer | 53 | 20-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deirdre Connelly
CHM | Chairman | 63 | 16-12-31 |
Director/Board Member | 73 | 03-10-31 | |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.28% | 1 M€ | -4.80% | - | |
1.99% | 0 M€ | 0.00% | - | |
1.68% | 0 M€ | 0.00% | - | |
1.47% | 9 M€ | -4.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 27.72 | -3.58% | 667,530 |
24-05-01 | 28.75 | +3.83% | 876,260 |
24-04-30 | 27.69 | -3.08% | 933,126 |
24-04-29 | 28.57 | +1.49% | 593,112 |
24-04-26 | 28.15 | +2.51% | 339,610 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B | |
+307.09% | 8.43B |
- Stock Market
- Equities
- GMAB Stock
- GMAB Stock